Skip to main content

Table 6 Adjusted multivariate model of factors associated with use of stimulating prescription drugs

From: Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population

Variables

step 1a

step 6a

Coeff. (SE)

OR (95% CI)

p

VIF

Coeff. (SE)

OR (95% CI)

p

R 2b

BRS

−.72 (.42)

.49 (.21–1.12)

.09

2.11

.45

PSS-4

.78 (.43)

2.19 (.95–5.05)

.07

1.75

1.05 (.33)

2.86 (1.49–5.46)

<.01

SOP-2

.01 (.38)

1.00 (.48–2.13)

.98

1.76

ASKU

.07 (.5)

1.07 (.40–2.82)

.90

1.76

IE-I

.18 (.43)

1.19 (.52–2.74)

.68

1.66

IE-E

−.16 (.38)

.86 (.40–1.81)

.68

1.60

Sex:

 Male

Reference

1.15

Reference

 Female

−.15 (.60)

.86 (.27–2.76)

.80

 

Age

−.89 (.47)

.41 (.17–1.03)

.06

1.21

.53 (.20)

1.70 (1.15–2.50)

<.01

Education:

 No formal degree

Reference

1.11

Reference

 Secondary modern school

n.a.

n.a.

n.a.

 

 Middle school

−1.21 (.83)

.30 (.06–1.53)

.15

 

 University-entrance diploma

.07 (.81)

1.08 (.22–5.28).

.93

 

 University degree

−.61 (1.09)

.54 (.06–4.61)

.57

 

Current or last professional position:

 Skilled worker

Reference

 

Reference

 Executive employee

2.16 (1.25)

8.69 (.75–100.30)

.08

1.05

 Non-executive employee

1.00 (1.15)

2.72 (.29–25.62)

.38

 

 Civil servants

1.78 (1.75)

5.92 (.19–181.33)

.31

 

 Self-employed

2.74 (1.41)

15.44 (.98–242.95)

.05

 

 Other

1.76 (1.42)

5.81 (.36–94.30)

.22

 

Place of residence:

 North Rhine-Westphalia

Reference

1.10

Reference

 Hamburg

.07 (1.55)

1.07 (0.05–22.47)

.96

 

 Lower Saxony

−1.67 (1.59)

.19 (.01–4.26)

.29

 

 Bremen

n.a.

n.a.

n.a.

 

 Schleswig Holstein

.17 (1.53)

1.18 (.06–23.60)

.91

 

 Hesse

.10 (1.09)

1.10 (.13–9.27)

.93

 

 Rhineland-Palatine

.70 (1.38)

2.01 (.13–30.15)

.61

 

 Baden-Wuerttemberg

.51 (.86)

1.66 (.31–9.03)

.56

 

 Bavaria

−.61 (.97)

.54 (.08–3.63)

.53

 

 Saarland

n.a.

n.a.

n.a.

 

 Berlin

n.a.

n.a.

n.a.

 

 Brandenburg

1.389 (2.18

3.98 (.06–286.58)

.53

 

 Mecklenburg-Western Pomerania

n.a.

n.a.

n.a.

 

 Saxony

−.09 (1.23)

.92 (.08–10.23)

.94

 

 Saxony-Anhalt

n.a.

n.a.

n.a.

 

 Thuringia

n.a.

n.a.

n.a.

 

−2.62 (1.32)

.07 (.01–.97)

.05

Soft enhancer intake:

 No

Reference

1.09

Reference

 Yes

2.63 (1.12)

13.83 (1.55–123.54)

.02

 

2.25 (.34)

9.49 (4.86–18.52)

<.001

  1. Logistic regression with backward elimination) of factors associated with use of stimulating prescription drugs (users n = 48; non-users = 686). First step and final step. n.a. = no data available
  2. Further notes see Table 3